Krajina: Izrael
Jazyk: angličtina
Zdroj: Ministry of Health
FACTOR VIII HUMAN COAGULATION VHSD TREATED 500 IU/VIAL
TEVA MEDICAL MARKETING LTD.
B02BD02
POWDER FOR SOLUTION FOR INJECTION
I.V
BAXTER AG, AUSTRIA
COAGULATION FACTOR VIII
Treatment and prophylaxis of bleeding in patients with congenital (haemophilia A) or acquired factor VIII deficiency. Von Willebrand's disease with factor VIII deficiency.
2011-10-01